BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pancreas
,
Neocentromeres
,
Quercetin
,
rs7903146
,
PDX1
,
Metabolism of xenobiotics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
agonist- nicotinic
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Explore Curated Studies Results
Literature
Most Relevant Literature
The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acu…
Analgesic effects mediated by neuronal nicotinic acetylcholine receptor agonists: correlation with d…
Partial agonists for α4β2 nicotinic receptors stimulate dopaminergic neuron firing with relatively e…
A fluorinated quinuclidine benzamide named LMA 10203 acts as an agonist of insect nicotinic acetylch…
The nicotinic α7 receptor agonist GTS-21 improves cognitive performance in ketamine impaired rhesus …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Parkinson's Disease With Mild Cognitive Impairment Treated With Nicotinic Agonist Drug
Phase 2 Trial of a Nicotinic Agonist in Schizophrenia
Nicotinic Agonist Effects on BMI and Neuronal Response
Phase I Nicotinic Agonist Treatment Trial for Autism
Safety and Efficacy of the Novel Selective Nicotinic Receptor Partial Agonist, CHANTIX (Varenicline)…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ